Early Trial Offers Hope Treating Rare ‘Brittle Bone’ Disease
By Amy Norton HealthDay Reporter MONDAY, Feb. 21, 2022 (HealthDay News) — An experimental drug may help build bone mass in some adults with a rare brittle-bone disease, a small preliminary study suggests. The disease is called osteogenesis imperfecta. It’s caused by defects in certain genes involved in making collagen — a key protein in … Read more